Short Interest in bioMérieux S.A. (OTCMKTS:BMXMF) Expands By 100.9%

bioMérieux S.A. (OTCMKTS:BMXMF - Get Free Report) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 260,000 shares, a growth of 100.9% from the March 31st total of 129,400 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,600.0 days. Currently, 0.2% of the shares of the stock are sold short.

bioMérieux Stock Performance

OTCMKTS:BMXMF remained flat at $130.75 on Monday. The firm has a fifty day moving average price of $124.56 and a two-hundred day moving average price of $115.16. bioMérieux has a 1 year low of $93.50 and a 1 year high of $131.75. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.20 and a current ratio of 2.21.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.